Page 37 - Hawkary2017

Ajanta Pharma

Micro Labs

Ajanta Pharma is a specialty pharmaceutical company engaged in
development, manufacture and marketing of quality finished
dosages in domestic and international markets. Established in 1973 Micro Labs Limited is a multi-faceted healthcare organization with a
and headquartered in Mumbai-India, we are committed to 'Serve proficient marketing team, state-of-the-art manufacturing facilities
Health Care Needs Worldwide'. Ajanta has been consistently and R&D centres that are at par with international standards. All this,
providing high quality affordable medicines to patients in different robustly backed by a strong distribution network and path-breaking
parts of the world. research work has placed us amongst India’s fast growing
transnational healthcare organizations.
We employ over 5,000 people worldwide and our products are sold
th
in over 40 countries. Ajanta operates with five state-of-the art Ranking 10 among prescriptions and 20 in sales, Micro’s brand
th
manufacturing facilities that produce high quality pharmaceutical portfolio includes some of the topmost brands in various specialties
products. We focus on commercializing unique generic products and like Cardiology, Diabetology, Anti-infectives, Ophthalmology, Pain,
pioneering synergistic combination products in the therapeutic etc. Amidst our proud achievers is Dolo, an award-winning brand
areas of anti-malarial, Cardiovascular, dermatology, male erectile highly prescribed for fever management.
dysfunction, musculoskeletal, and ophthalmology.
The company is also at the forefront in social contribution, striving to
In India, we have significant presence in the fast growing specialty be a model corporate citizen in terms of Environmental Protection &
therapeutic segments of Cardiovascular, dermatology, Social Initiatives with significant contributions in the areas of
ophthalmology and musculoskeletal. With primary focus on new education and health.
product innovation and introduction, we have been consistently
identifying unmet medical needs and introducing many Micro Labs is poised to achieve unparalleled status in the global
first-to-market products to cater to those needs. Our products pharmaceutical industry. Backed by a profound and resolute vision,
provide patient compliance and convenience over existing we now have our eyes set on attaining the 1 billion USD mark by 2015.
therapeutic options. Gaining first mover advantage, many of our
brands hold leadership positions in their respective sub-therapeutic
segments.

Ajanta has extensive presence in many countries in Asia, Africa and
Latin America with customized product portfolio to suit the needs of
each country. Having successfully gone through USFDA inspection,
we have started commercial operations in the US market in the first
quarter of 2013. With a portfolio of 25 ANDAs which have been filed
with the US FDA, we look forward to the US market to be our key
growth driver in coming years.

33
30 Our Suppliers Portfolio - Hawkary 2017 23
26 Our Suppliers Portfolio - Hawkary 2017